[
    {
        "molecule_name": "Immunoglobulin G",
        "protein_target_name": "FcRn",
        "binding_metric": "Kd",
        "value": "<10^5",
        "unit": "moles/liter",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The interaction between FcRn and IgG is exquisitely sensitive to pH, being reduced over 2 orders of magnitude as the pH is raised from pH 6.0 to 7.0, with a dissociation constant (Kd) that is not explicitly stated but implied to be in the range of 10^5 moles/liter or less under the first biological condition.\n* When steps b) and c) are performed as part of a single screening process, such a screening process may for example comprise the steps of: i) bringing the set, collection or library of amino acid sequences in contact with the desired molecule under the first biological condition (i.e. such that amino acid sequences that can bind to said desired molecule with a dissociation constant (Kd) of 10^5 moles/liter or less bind to the desired molecule, and such that amino acid sequences that can not bind to said desired molecule with a dissociation constant (Kd) of 10^5 moles/liter or less do not bind to the desired molecule);\n\nNote that the text does not provide many explicit examples of molecules with specific bioactivity metrics, numeric values, and units. The extracted sentences are the closest matches to the criteria, but may not perfectly meet all the requirements."
    },
    {
        "molecule_name": "amino acid sequence of the invention",
        "protein_target_name": "serum protein",
        "binding_metric": "K_D",
        "value": "10^5",
        "unit": "moles/liter",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\na) binds to said serum protein under a first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>5</sup> M<sup>-1</sup>;\n\n\nPreferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less.\n\n\nAlso, preferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less, e.g. 10<sup>8</sup> moles/liter or less or 10<sup>9</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 3x10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less."
    },
    {
        "molecule_name": "amino acid sequence of the invention",
        "protein_target_name": "serum protein",
        "binding_metric": "K_D",
        "value": "10^6",
        "unit": "moles/liter",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\na) binds to said serum protein under a first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>5</sup> M<sup>-1</sup>;\n\n\nPreferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less.\n\n\nAlso, preferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less, e.g. 10<sup>8</sup> moles/liter or less or 10<sup>9</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 3x10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less."
    },
    {
        "molecule_name": "amino acid sequence of the invention",
        "protein_target_name": "serum protein",
        "binding_metric": "K_D",
        "value": "10^7",
        "unit": "moles/liter",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\na) binds to said serum protein under a first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>5</sup> M<sup>-1</sup>;\n\n\nPreferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less.\n\n\nAlso, preferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less, e.g. 10<sup>8</sup> moles/liter or less or 10<sup>9</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 3x10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less."
    },
    {
        "molecule_name": "amino acid sequence of the invention",
        "protein_target_name": "serum protein",
        "binding_metric": "K_D",
        "value": "10^6",
        "unit": "moles/liter",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\na) binds to said serum protein under a first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>5</sup> M<sup>-1</sup>;\n\n\nPreferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less.\n\n\nAlso, preferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less, e.g. 10<sup>8</sup> moles/liter or less or 10<sup>9</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 3x10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less."
    },
    {
        "molecule_name": "amino acid sequence of the invention",
        "protein_target_name": "serum protein",
        "binding_metric": "K_D",
        "value": "10^5",
        "unit": "moles/liter",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\na) binds to said serum protein under a first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>5</sup> M<sup>-1</sup>;\n\n\nPreferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less.\n\n\nAlso, preferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less, e.g. 10<sup>8</sup> moles/liter or less or 10<sup>9</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 3x10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less."
    },
    {
        "molecule_name": "amino acid sequence of the invention",
        "protein_target_name": "serum protein",
        "binding_metric": "K_D",
        "value": "10^4",
        "unit": "moles/liter",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\na) binds to said serum protein under a first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>5</sup> M<sup>-1</sup>;\n\n\nPreferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less.\n\n\nAlso, preferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less, e.g. 10<sup>8</sup> moles/liter or less or 10<sup>9</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 3x10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less."
    },
    {
        "molecule_name": "amino acid sequence of the invention",
        "protein_target_name": "serum protein",
        "binding_metric": "K_D",
        "value": "10^6",
        "unit": "moles/liter",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\na) binds to said serum protein under a first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>5</sup> M<sup>-1</sup>;\n\n\nPreferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less.\n\n\nAlso, preferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less, e.g. 10<sup>8</sup> moles/liter or less or 10<sup>9</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 3x10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less."
    },
    {
        "molecule_name": "amino acid sequence of the invention",
        "protein_target_name": "serum protein",
        "binding_metric": "K_D",
        "value": "3x10^6",
        "unit": "moles/liter",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\na) binds to said serum protein under a first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>5</sup> M<sup>-1</sup>;\n\n\nPreferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less.\n\n\nAlso, preferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less, e.g. 10<sup>8</sup> moles/liter or less or 10<sup>9</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 3x10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less."
    },
    {
        "molecule_name": "amino acid sequence of the invention",
        "protein_target_name": "serum protein",
        "binding_metric": "K_D",
        "value": "10^7",
        "unit": "moles/liter",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\na) binds to said serum protein under a first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>5</sup> M<sup>-1</sup>;\n\n\nPreferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less.\n\n\nAlso, preferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less, e.g. 10<sup>8</sup> moles/liter or less or 10<sup>9</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 3x10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less."
    },
    {
        "molecule_name": "amino acid sequence of the invention",
        "protein_target_name": "serum protein",
        "binding_metric": "K_D",
        "value": "10^8",
        "unit": "moles/liter",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\na) binds to said serum protein under a first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>5</sup> M<sup>-1</sup>;\n\n\nPreferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less.\n\n\nAlso, preferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less, e.g. 10<sup>8</sup> moles/liter or less or 10<sup>9</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 3x10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less."
    },
    {
        "molecule_name": "amino acid sequence of the invention",
        "protein_target_name": "serum protein",
        "binding_metric": "K_D",
        "value": "10^9",
        "unit": "moles/liter",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\na) binds to said serum protein under a first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>5</sup> M<sup>-1</sup>;\n\n\nPreferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less.\n\n\nAlso, preferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less, e.g. 10<sup>8</sup> moles/liter or less or 10<sup>9</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 3x10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less."
    },
    {
        "molecule_name": "amino acid sequence of the invention",
        "protein_target_name": "serum protein",
        "binding_metric": "K_D",
        "value": "10^5",
        "unit": "moles/liter",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\na) binds to said serum protein under a first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>5</sup> M<sup>-1</sup>;\n\n\nPreferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less.\n\n\nAlso, preferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less, e.g. 10<sup>8</sup> moles/liter or less or 10<sup>9</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 3x10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less."
    },
    {
        "molecule_name": "amino acid sequence of the invention",
        "protein_target_name": "serum protein",
        "binding_metric": "K_D",
        "value": "10^6",
        "unit": "moles/liter",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\na) binds to said serum protein under a first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>5</sup> M<sup>-1</sup>;\n\n\nPreferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less.\n\n\nAlso, preferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less, e.g. 10<sup>8</sup> moles/liter or less or 10<sup>9</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 3x10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less."
    },
    {
        "molecule_name": "amino acid sequence of the invention",
        "protein_target_name": "serum protein",
        "binding_metric": "K_D",
        "value": "10^7",
        "unit": "moles/liter",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\na) binds to said serum protein under a first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>5</sup> M<sup>-1</sup>;\n\n\nPreferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less.\n\n\nAlso, preferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less, e.g. 10<sup>8</sup> moles/liter or less or 10<sup>9</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 3x10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less."
    },
    {
        "molecule_name": "amino acid sequence of the invention",
        "protein_target_name": "serum protein",
        "binding_metric": "K_D",
        "value": "10^8",
        "unit": "moles/liter",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\na) binds to said serum protein under a first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>5</sup> M<sup>-1</sup>;\n\n\nPreferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less.\n\n\nAlso, preferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less, e.g. 10<sup>8</sup> moles/liter or less or 10<sup>9</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 3x10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less."
    },
    {
        "molecule_name": "amino acid sequence of the invention",
        "protein_target_name": "serum protein",
        "binding_metric": "K_D",
        "value": "10^4",
        "unit": "moles/liter",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\na) binds to said serum protein under a first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>5</sup> M<sup>-1</sup>;\n\n\nPreferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less.\n\n\nAlso, preferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less, e.g. 10<sup>8</sup> moles/liter or less or 10<sup>9</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 3x10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less."
    },
    {
        "molecule_name": "amino acid sequence of the invention",
        "protein_target_name": "serum protein",
        "binding_metric": "K_D",
        "value": "10^6",
        "unit": "moles/liter",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\na) binds to said serum protein under a first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>5</sup> M<sup>-1</sup>;\n\n\nPreferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less.\n\n\nAlso, preferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less, e.g. 10<sup>8</sup> moles/liter or less or 10<sup>9</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 3x10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less."
    },
    {
        "molecule_name": "amino acid sequence of the invention",
        "protein_target_name": "serum protein",
        "binding_metric": "K_D",
        "value": "10^7",
        "unit": "moles/liter",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\na) binds to said serum protein under a first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>5</sup> M<sup>-1</sup>;\n\n\nPreferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less.\n\n\nAlso, preferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less, e.g. 10<sup>8</sup> moles/liter or less or 10<sup>9</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 3x10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less."
    },
    {
        "molecule_name": "amino acid sequence of the invention",
        "protein_target_name": "serum protein",
        "binding_metric": "K_D",
        "value": "10^8",
        "unit": "moles/liter",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\na) binds to said serum protein under a first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>5</sup> M<sup>-1</sup>;\n\n\nPreferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or less, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less.\n\n\nAlso, preferably, according to this embodiment, the amino acid sequence of the invention binds to said serum protein under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, more preferably with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>7</sup> moles/liter or less, e.g. 10<sup>8</sup> moles/liter or less or 10<sup>9</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>5</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 3x10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less.\n\n\nIn another embodiment of this invention, the amino acid sequence of the invention binds to said serum protein under said first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>4</sup> moles/liter or more, and under said second biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>6</sup> moles/liter or less, e.g. 10<sup>7</sup> moles/liter or less; or e.g. 10<sup>8</sup> moles/liter or less."
    },
    {
        "molecule_name": "monovalent immunoglobulin sequence",
        "protein_target_name": "human serum albumin",
        "binding_metric": "Kd",
        "value": "10^5 to 10^12",
        "unit": "moles/liter",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nWhen an amino acid sequence as described herein is a monovalent immunoglobulin sequence (for example, a monovalent Nanobody), said monovalent immunoglobulin sequence preferably binds to human serum albumin under the first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>'5</sup> to 10<sup>\"!2</sup> moles/liter or less, and preferably 10<sup>\"7</sup> to 1(X<sup>12</sup> moles/liter or less and more preferably I0<sup>\"8</sup> to 10<sup>\"!2</sup> moles/liter (i.e. with an association constant (K<sub>A</sub>) of 10<sup>5</sup> to 10<sup>12</sup> liter/ moles or more, and preferably 10<sup>7</sup> to 10<sup>12</sup> liter/moles or more and more preferably 10<sup>8</sup> to 10<sup>12</sup> liter/moles, and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>7</sup> M<sup>\"1</sup>, preferably at least 10<sup>8</sup> M<sup>\"1</sup>, more preferably at least 10<sup>9</sup> M<sup>\"1</sup>, such as at least 10<sup>12</sup> M<sup>\"1</sup>.\nPreferably, a monovalent immunoglobulin sequence of this embodiment will bind to the desired serum protein under the first biological condition with an affinity less than 3000 nM, preferably less than 300 nM, more preferably less than 30 nM, such as less than 3 nM."
    },
    {
        "molecule_name": "monovalent immunoglobulin sequence",
        "protein_target_name": "human serum albumin",
        "binding_metric": "Kd",
        "value": "10^7 to 10^12",
        "unit": "moles/liter",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nWhen an amino acid sequence as described herein is a monovalent immunoglobulin sequence (for example, a monovalent Nanobody), said monovalent immunoglobulin sequence preferably binds to human serum albumin under the first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>'5</sup> to 10<sup>\"!2</sup> moles/liter or less, and preferably 10<sup>\"7</sup> to 1(X<sup>12</sup> moles/liter or less and more preferably I0<sup>\"8</sup> to 10<sup>\"!2</sup> moles/liter (i.e. with an association constant (K<sub>A</sub>) of 10<sup>5</sup> to 10<sup>12</sup> liter/ moles or more, and preferably 10<sup>7</sup> to 10<sup>12</sup> liter/moles or more and more preferably 10<sup>8</sup> to 10<sup>12</sup> liter/moles, and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>7</sup> M<sup>\"1</sup>, preferably at least 10<sup>8</sup> M<sup>\"1</sup>, more preferably at least 10<sup>9</sup> M<sup>\"1</sup>, such as at least 10<sup>12</sup> M<sup>\"1</sup>.\nPreferably, a monovalent immunoglobulin sequence of this embodiment will bind to the desired serum protein under the first biological condition with an affinity less than 3000 nM, preferably less than 300 nM, more preferably less than 30 nM, such as less than 3 nM."
    },
    {
        "molecule_name": "monovalent immunoglobulin sequence",
        "protein_target_name": "human serum albumin",
        "binding_metric": "Kd",
        "value": "10^8 to 10^12",
        "unit": "moles/liter",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nWhen an amino acid sequence as described herein is a monovalent immunoglobulin sequence (for example, a monovalent Nanobody), said monovalent immunoglobulin sequence preferably binds to human serum albumin under the first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>'5</sup> to 10<sup>\"!2</sup> moles/liter or less, and preferably 10<sup>\"7</sup> to 1(X<sup>12</sup> moles/liter or less and more preferably I0<sup>\"8</sup> to 10<sup>\"!2</sup> moles/liter (i.e. with an association constant (K<sub>A</sub>) of 10<sup>5</sup> to 10<sup>12</sup> liter/ moles or more, and preferably 10<sup>7</sup> to 10<sup>12</sup> liter/moles or more and more preferably 10<sup>8</sup> to 10<sup>12</sup> liter/moles, and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>7</sup> M<sup>\"1</sup>, preferably at least 10<sup>8</sup> M<sup>\"1</sup>, more preferably at least 10<sup>9</sup> M<sup>\"1</sup>, such as at least 10<sup>12</sup> M<sup>\"1</sup>.\nPreferably, a monovalent immunoglobulin sequence of this embodiment will bind to the desired serum protein under the first biological condition with an affinity less than 3000 nM, preferably less than 300 nM, more preferably less than 30 nM, such as less than 3 nM."
    },
    {
        "molecule_name": "monovalent immunoglobulin sequence",
        "protein_target_name": "human serum albumin",
        "binding_metric": "Ka",
        "value": "10^5 to 10^12",
        "unit": "liter/moles",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nWhen an amino acid sequence as described herein is a monovalent immunoglobulin sequence (for example, a monovalent Nanobody), said monovalent immunoglobulin sequence preferably binds to human serum albumin under the first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>'5</sup> to 10<sup>\"!2</sup> moles/liter or less, and preferably 10<sup>\"7</sup> to 1(X<sup>12</sup> moles/liter or less and more preferably I0<sup>\"8</sup> to 10<sup>\"!2</sup> moles/liter (i.e. with an association constant (K<sub>A</sub>) of 10<sup>5</sup> to 10<sup>12</sup> liter/ moles or more, and preferably 10<sup>7</sup> to 10<sup>12</sup> liter/moles or more and more preferably 10<sup>8</sup> to 10<sup>12</sup> liter/moles, and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>7</sup> M<sup>\"1</sup>, preferably at least 10<sup>8</sup> M<sup>\"1</sup>, more preferably at least 10<sup>9</sup> M<sup>\"1</sup>, such as at least 10<sup>12</sup> M<sup>\"1</sup>.\nPreferably, a monovalent immunoglobulin sequence of this embodiment will bind to the desired serum protein under the first biological condition with an affinity less than 3000 nM, preferably less than 300 nM, more preferably less than 30 nM, such as less than 3 nM."
    },
    {
        "molecule_name": "monovalent immunoglobulin sequence",
        "protein_target_name": "human serum albumin",
        "binding_metric": "Ka",
        "value": "10^7 to 10^12",
        "unit": "liter/moles",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nWhen an amino acid sequence as described herein is a monovalent immunoglobulin sequence (for example, a monovalent Nanobody), said monovalent immunoglobulin sequence preferably binds to human serum albumin under the first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>'5</sup> to 10<sup>\"!2</sup> moles/liter or less, and preferably 10<sup>\"7</sup> to 1(X<sup>12</sup> moles/liter or less and more preferably I0<sup>\"8</sup> to 10<sup>\"!2</sup> moles/liter (i.e. with an association constant (K<sub>A</sub>) of 10<sup>5</sup> to 10<sup>12</sup> liter/ moles or more, and preferably 10<sup>7</sup> to 10<sup>12</sup> liter/moles or more and more preferably 10<sup>8</sup> to 10<sup>12</sup> liter/moles, and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>7</sup> M<sup>\"1</sup>, preferably at least 10<sup>8</sup> M<sup>\"1</sup>, more preferably at least 10<sup>9</sup> M<sup>\"1</sup>, such as at least 10<sup>12</sup> M<sup>\"1</sup>.\nPreferably, a monovalent immunoglobulin sequence of this embodiment will bind to the desired serum protein under the first biological condition with an affinity less than 3000 nM, preferably less than 300 nM, more preferably less than 30 nM, such as less than 3 nM."
    },
    {
        "molecule_name": "monovalent immunoglobulin sequence",
        "protein_target_name": "human serum albumin",
        "binding_metric": "Ka",
        "value": "10^8 to 10^12",
        "unit": "liter/moles",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nWhen an amino acid sequence as described herein is a monovalent immunoglobulin sequence (for example, a monovalent Nanobody), said monovalent immunoglobulin sequence preferably binds to human serum albumin under the first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>'5</sup> to 10<sup>\"!2</sup> moles/liter or less, and preferably 10<sup>\"7</sup> to 1(X<sup>12</sup> moles/liter or less and more preferably I0<sup>\"8</sup> to 10<sup>\"!2</sup> moles/liter (i.e. with an association constant (K<sub>A</sub>) of 10<sup>5</sup> to 10<sup>12</sup> liter/ moles or more, and preferably 10<sup>7</sup> to 10<sup>12</sup> liter/moles or more and more preferably 10<sup>8</sup> to 10<sup>12</sup> liter/moles, and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>7</sup> M<sup>\"1</sup>, preferably at least 10<sup>8</sup> M<sup>\"1</sup>, more preferably at least 10<sup>9</sup> M<sup>\"1</sup>, such as at least 10<sup>12</sup> M<sup>\"1</sup>.\nPreferably, a monovalent immunoglobulin sequence of this embodiment will bind to the desired serum protein under the first biological condition with an affinity less than 3000 nM, preferably less than 300 nM, more preferably less than 30 nM, such as less than 3 nM."
    },
    {
        "molecule_name": "monovalent immunoglobulin sequence",
        "protein_target_name": "human serum albumin",
        "binding_metric": "Ka",
        "value": "at least 10^7",
        "unit": "M^-1",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nWhen an amino acid sequence as described herein is a monovalent immunoglobulin sequence (for example, a monovalent Nanobody), said monovalent immunoglobulin sequence preferably binds to human serum albumin under the first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>'5</sup> to 10<sup>\"!2</sup> moles/liter or less, and preferably 10<sup>\"7</sup> to 1(X<sup>12</sup> moles/liter or less and more preferably I0<sup>\"8</sup> to 10<sup>\"!2</sup> moles/liter (i.e. with an association constant (K<sub>A</sub>) of 10<sup>5</sup> to 10<sup>12</sup> liter/ moles or more, and preferably 10<sup>7</sup> to 10<sup>12</sup> liter/moles or more and more preferably 10<sup>8</sup> to 10<sup>12</sup> liter/moles, and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>7</sup> M<sup>\"1</sup>, preferably at least 10<sup>8</sup> M<sup>\"1</sup>, more preferably at least 10<sup>9</sup> M<sup>\"1</sup>, such as at least 10<sup>12</sup> M<sup>\"1</sup>.\nPreferably, a monovalent immunoglobulin sequence of this embodiment will bind to the desired serum protein under the first biological condition with an affinity less than 3000 nM, preferably less than 300 nM, more preferably less than 30 nM, such as less than 3 nM."
    },
    {
        "molecule_name": "monovalent immunoglobulin sequence",
        "protein_target_name": "human serum albumin",
        "binding_metric": "Ka",
        "value": "at least 10^8",
        "unit": "M^-1",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nWhen an amino acid sequence as described herein is a monovalent immunoglobulin sequence (for example, a monovalent Nanobody), said monovalent immunoglobulin sequence preferably binds to human serum albumin under the first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>'5</sup> to 10<sup>\"!2</sup> moles/liter or less, and preferably 10<sup>\"7</sup> to 1(X<sup>12</sup> moles/liter or less and more preferably I0<sup>\"8</sup> to 10<sup>\"!2</sup> moles/liter (i.e. with an association constant (K<sub>A</sub>) of 10<sup>5</sup> to 10<sup>12</sup> liter/ moles or more, and preferably 10<sup>7</sup> to 10<sup>12</sup> liter/moles or more and more preferably 10<sup>8</sup> to 10<sup>12</sup> liter/moles, and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>7</sup> M<sup>\"1</sup>, preferably at least 10<sup>8</sup> M<sup>\"1</sup>, more preferably at least 10<sup>9</sup> M<sup>\"1</sup>, such as at least 10<sup>12</sup> M<sup>\"1</sup>.\nPreferably, a monovalent immunoglobulin sequence of this embodiment will bind to the desired serum protein under the first biological condition with an affinity less than 3000 nM, preferably less than 300 nM, more preferably less than 30 nM, such as less than 3 nM."
    },
    {
        "molecule_name": "monovalent immunoglobulin sequence",
        "protein_target_name": "human serum albumin",
        "binding_metric": "Ka",
        "value": "at least 10^9",
        "unit": "M^-1",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nWhen an amino acid sequence as described herein is a monovalent immunoglobulin sequence (for example, a monovalent Nanobody), said monovalent immunoglobulin sequence preferably binds to human serum albumin under the first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>'5</sup> to 10<sup>\"!2</sup> moles/liter or less, and preferably 10<sup>\"7</sup> to 1(X<sup>12</sup> moles/liter or less and more preferably I0<sup>\"8</sup> to 10<sup>\"!2</sup> moles/liter (i.e. with an association constant (K<sub>A</sub>) of 10<sup>5</sup> to 10<sup>12</sup> liter/ moles or more, and preferably 10<sup>7</sup> to 10<sup>12</sup> liter/moles or more and more preferably 10<sup>8</sup> to 10<sup>12</sup> liter/moles, and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>7</sup> M<sup>\"1</sup>, preferably at least 10<sup>8</sup> M<sup>\"1</sup>, more preferably at least 10<sup>9</sup> M<sup>\"1</sup>, such as at least 10<sup>12</sup> M<sup>\"1</sup>.\nPreferably, a monovalent immunoglobulin sequence of this embodiment will bind to the desired serum protein under the first biological condition with an affinity less than 3000 nM, preferably less than 300 nM, more preferably less than 30 nM, such as less than 3 nM."
    },
    {
        "molecule_name": "monovalent immunoglobulin sequence",
        "protein_target_name": "human serum albumin",
        "binding_metric": "Ka",
        "value": "at least 10^12",
        "unit": "M^-1",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nWhen an amino acid sequence as described herein is a monovalent immunoglobulin sequence (for example, a monovalent Nanobody), said monovalent immunoglobulin sequence preferably binds to human serum albumin under the first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>'5</sup> to 10<sup>\"!2</sup> moles/liter or less, and preferably 10<sup>\"7</sup> to 1(X<sup>12</sup> moles/liter or less and more preferably I0<sup>\"8</sup> to 10<sup>\"!2</sup> moles/liter (i.e. with an association constant (K<sub>A</sub>) of 10<sup>5</sup> to 10<sup>12</sup> liter/ moles or more, and preferably 10<sup>7</sup> to 10<sup>12</sup> liter/moles or more and more preferably 10<sup>8</sup> to 10<sup>12</sup> liter/moles, and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>7</sup> M<sup>\"1</sup>, preferably at least 10<sup>8</sup> M<sup>\"1</sup>, more preferably at least 10<sup>9</sup> M<sup>\"1</sup>, such as at least 10<sup>12</sup> M<sup>\"1</sup>.\nPreferably, a monovalent immunoglobulin sequence of this embodiment will bind to the desired serum protein under the first biological condition with an affinity less than 3000 nM, preferably less than 300 nM, more preferably less than 30 nM, such as less than 3 nM."
    },
    {
        "molecule_name": "monovalent immunoglobulin sequence",
        "protein_target_name": "desired serum protein",
        "binding_metric": "affinity",
        "value": "< 3000",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nWhen an amino acid sequence as described herein is a monovalent immunoglobulin sequence (for example, a monovalent Nanobody), said monovalent immunoglobulin sequence preferably binds to human serum albumin under the first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>'5</sup> to 10<sup>\"!2</sup> moles/liter or less, and preferably 10<sup>\"7</sup> to 1(X<sup>12</sup> moles/liter or less and more preferably I0<sup>\"8</sup> to 10<sup>\"!2</sup> moles/liter (i.e. with an association constant (K<sub>A</sub>) of 10<sup>5</sup> to 10<sup>12</sup> liter/ moles or more, and preferably 10<sup>7</sup> to 10<sup>12</sup> liter/moles or more and more preferably 10<sup>8</sup> to 10<sup>12</sup> liter/moles, and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>7</sup> M<sup>\"1</sup>, preferably at least 10<sup>8</sup> M<sup>\"1</sup>, more preferably at least 10<sup>9</sup> M<sup>\"1</sup>, such as at least 10<sup>12</sup> M<sup>\"1</sup>.\nPreferably, a monovalent immunoglobulin sequence of this embodiment will bind to the desired serum protein under the first biological condition with an affinity less than 3000 nM, preferably less than 300 nM, more preferably less than 30 nM, such as less than 3 nM."
    },
    {
        "molecule_name": "monovalent immunoglobulin sequence",
        "protein_target_name": "desired serum protein",
        "binding_metric": "affinity",
        "value": "< 300",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nWhen an amino acid sequence as described herein is a monovalent immunoglobulin sequence (for example, a monovalent Nanobody), said monovalent immunoglobulin sequence preferably binds to human serum albumin under the first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>'5</sup> to 10<sup>\"!2</sup> moles/liter or less, and preferably 10<sup>\"7</sup> to 1(X<sup>12</sup> moles/liter or less and more preferably I0<sup>\"8</sup> to 10<sup>\"!2</sup> moles/liter (i.e. with an association constant (K<sub>A</sub>) of 10<sup>5</sup> to 10<sup>12</sup> liter/ moles or more, and preferably 10<sup>7</sup> to 10<sup>12</sup> liter/moles or more and more preferably 10<sup>8</sup> to 10<sup>12</sup> liter/moles, and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>7</sup> M<sup>\"1</sup>, preferably at least 10<sup>8</sup> M<sup>\"1</sup>, more preferably at least 10<sup>9</sup> M<sup>\"1</sup>, such as at least 10<sup>12</sup> M<sup>\"1</sup>.\nPreferably, a monovalent immunoglobulin sequence of this embodiment will bind to the desired serum protein under the first biological condition with an affinity less than 3000 nM, preferably less than 300 nM, more preferably less than 30 nM, such as less than 3 nM."
    },
    {
        "molecule_name": "monovalent immunoglobulin sequence",
        "protein_target_name": "desired serum protein",
        "binding_metric": "affinity",
        "value": "< 30",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nWhen an amino acid sequence as described herein is a monovalent immunoglobulin sequence (for example, a monovalent Nanobody), said monovalent immunoglobulin sequence preferably binds to human serum albumin under the first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>'5</sup> to 10<sup>\"!2</sup> moles/liter or less, and preferably 10<sup>\"7</sup> to 1(X<sup>12</sup> moles/liter or less and more preferably I0<sup>\"8</sup> to 10<sup>\"!2</sup> moles/liter (i.e. with an association constant (K<sub>A</sub>) of 10<sup>5</sup> to 10<sup>12</sup> liter/ moles or more, and preferably 10<sup>7</sup> to 10<sup>12</sup> liter/moles or more and more preferably 10<sup>8</sup> to 10<sup>12</sup> liter/moles, and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>7</sup> M<sup>\"1</sup>, preferably at least 10<sup>8</sup> M<sup>\"1</sup>, more preferably at least 10<sup>9</sup> M<sup>\"1</sup>, such as at least 10<sup>12</sup> M<sup>\"1</sup>.\nPreferably, a monovalent immunoglobulin sequence of this embodiment will bind to the desired serum protein under the first biological condition with an affinity less than 3000 nM, preferably less than 300 nM, more preferably less than 30 nM, such as less than 3 nM."
    },
    {
        "molecule_name": "monovalent immunoglobulin sequence",
        "protein_target_name": "desired serum protein",
        "binding_metric": "affinity",
        "value": "< 3",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nWhen an amino acid sequence as described herein is a monovalent immunoglobulin sequence (for example, a monovalent Nanobody), said monovalent immunoglobulin sequence preferably binds to human serum albumin under the first biological condition with a dissociation constant (K<sub>D</sub>) of 10<sup>'5</sup> to 10<sup>\"!2</sup> moles/liter or less, and preferably 10<sup>\"7</sup> to 1(X<sup>12</sup> moles/liter or less and more preferably I0<sup>\"8</sup> to 10<sup>\"!2</sup> moles/liter (i.e. with an association constant (K<sub>A</sub>) of 10<sup>5</sup> to 10<sup>12</sup> liter/ moles or more, and preferably 10<sup>7</sup> to 10<sup>12</sup> liter/moles or more and more preferably 10<sup>8</sup> to 10<sup>12</sup> liter/moles, and/or with a binding affinity (K<sub>A</sub>) of at least 10<sup>7</sup> M<sup>\"1</sup>, preferably at least 10<sup>8</sup> M<sup>\"1</sup>, more preferably at least 10<sup>9</sup> M<sup>\"1</sup>, such as at least 10<sup>12</sup> M<sup>\"1</sup>.\nPreferably, a monovalent immunoglobulin sequence of this embodiment will bind to the desired serum protein under the first biological condition with an affinity less than 3000 nM, preferably less than 300 nM, more preferably less than 30 nM, such as less than 3 nM."
    },
    {
        "molecule_name": "Neonatal Fc receptor",
        "protein_target_name": "human albumin",
        "binding_metric": "Kd",
        "value": "1.8 to 3",
        "unit": "microM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The Kd at pH6 of human albumin for human FcRn is 1.8 to 3 microM (Chaudhury et al., 2006).\n* The Kd at pH6 for a wild type IgGl and human FcRn was found to be 2527nM (DaIF Acqua et al., 2002)."
    },
    {
        "molecule_name": "Immunoglobulin G1",
        "protein_target_name": "human FcRn",
        "binding_metric": "Kd",
        "value": "2527",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The Kd at pH6 of human albumin for human FcRn is 1.8 to 3 microM (Chaudhury et al., 2006).\n* The Kd at pH6 for a wild type IgGl and human FcRn was found to be 2527nM (DaIF Acqua et al., 2002)."
    }
]